Article Type
Changed
Thu, 12/15/2022 - 16:10
Display Headline
Does Deep Brain Stimulation of ANT Provide Sustained Efficacy and Safety?
Long-term efficacy and safety results of deep brain stimulation of ANT reported

Deep brain stimulation of the anterior nucleus of the thalamus (ANT) for treatment of localization-related epilepsy showed sustained efficacy and safety in this long-term follow-up of the SANTE trial. This study shows that ANT stimulation was associated with seizure frequency reduction rate of 69% at 5 years. The study also reported that 16% of subjects were seizure-free for ≥6 months during the 5 years of follow-up. ANT stimulation was associated with a 34% serious device-related adverse event rate at 5 years.

Salanova V, Witt T, Worth R, et al; SANTE Study Group. Long-term efficacy and safety of thalamic stimulation for drug resistant partial epilepsy. Neurology. 2015;84(10):1017-1025.

References

Author and Disclosure Information

Publications
Topics
Sections
Author and Disclosure Information

Author and Disclosure Information

Long-term efficacy and safety results of deep brain stimulation of ANT reported
Long-term efficacy and safety results of deep brain stimulation of ANT reported

Deep brain stimulation of the anterior nucleus of the thalamus (ANT) for treatment of localization-related epilepsy showed sustained efficacy and safety in this long-term follow-up of the SANTE trial. This study shows that ANT stimulation was associated with seizure frequency reduction rate of 69% at 5 years. The study also reported that 16% of subjects were seizure-free for ≥6 months during the 5 years of follow-up. ANT stimulation was associated with a 34% serious device-related adverse event rate at 5 years.

Salanova V, Witt T, Worth R, et al; SANTE Study Group. Long-term efficacy and safety of thalamic stimulation for drug resistant partial epilepsy. Neurology. 2015;84(10):1017-1025.

Deep brain stimulation of the anterior nucleus of the thalamus (ANT) for treatment of localization-related epilepsy showed sustained efficacy and safety in this long-term follow-up of the SANTE trial. This study shows that ANT stimulation was associated with seizure frequency reduction rate of 69% at 5 years. The study also reported that 16% of subjects were seizure-free for ≥6 months during the 5 years of follow-up. ANT stimulation was associated with a 34% serious device-related adverse event rate at 5 years.

Salanova V, Witt T, Worth R, et al; SANTE Study Group. Long-term efficacy and safety of thalamic stimulation for drug resistant partial epilepsy. Neurology. 2015;84(10):1017-1025.

References

References

Publications
Publications
Topics
Article Type
Display Headline
Does Deep Brain Stimulation of ANT Provide Sustained Efficacy and Safety?
Display Headline
Does Deep Brain Stimulation of ANT Provide Sustained Efficacy and Safety?
Sections
Article Source

PURLs Copyright

Inside the Article